🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you, Dr. Helen Shih! We loved having you as part of the invited prof lecture series. #radonc #CNSmetastases Duke Neurosurgery Duke Radiation Oncology Duke Cancer Mass General Cancer Center Amanda Van Swearingen, PhD Carey Anders Katy Peters Scott Floyd

Great updates from the Duke Neurosurgery brain tumor SPORE this morning at UCSF Neurosurgery. Neuro-onc fellow Kristen Batich MD PhD leading the way on CCL3 mediated DC migration and immune activation in GBM! 👏🏻 Duke GME Duke Cancer Duke Health

Polio Virotherapy Targets the Malignant Glioma Myeloid Infiltrate with Diffuse Microglia Activation Engulfing the CNS academic.oup.com/neuro-oncology…

Does WBRT “age” the brain? Anatomic surface-based deep learning to estimate brain age w/MRI before & after WBRT WBRT aged brain 9x faster than controls WBRT hippos aged 9x faster than HA-WBRT SRS alone NOT diff compared to controls academic.oup.com/neuro-oncology…

Finally Here. Dr. David Ashley kicks off #ICBTRT Duke Neurosurgery Duke Center for Brain and Spine Metastasis

DC migration center stage with Dr. Kristen Batich Duke Neurosurgery Duke Cancer Angels Among Us #ICBTRT

Congrats to Eugene Vaios, MD MBA, MD, MBA, who will represent Duke #RadOnc in the trainee poster session at the Duke University School of Medicine Dean's Research Series. His poster explores long-term safety/toxicity outcomes following dual immune-checkpoint blockade in brain metastasis patients receiving SRS

Thrilled to see this out! Great update on our understanding of radiation necrosis and avenues for discovery. Thanks to Sebastian F. Winter, MD PhD and our wonderful collaborators Duke Radiation Oncology Mass General Cancer Center Duke Cancer 👏🏻👏🏻👏🏻

📈Radiation necrosis is a growing challenge for brain metastasis patients in the era of combined modality therapy. This #review offers a critical appraisal of the literature and avenues for discovery✅ Find the full paper here👉mdpi.com/2072-6694/15/9… 👥by Eugene Vaios, MD MBA et al.

Ashley and Friedman Participate in Cancer Moonshot at the White House neurosurgery.duke.edu/news/ashley-an…

Thank you to the patients enrolled in INDIGO Duke Neurosurgery Duke Neurology Duke Cancer Angels Among Us

Dendritic cell vaccine trials in gliomas: Untangling the lines academic.oup.com/neuro-oncology…

Congrats to Dr. Batich, Mustafa Khasraw (find me in BlueSky), and the brain tumor team at Duke Neurosurgery Duke Cancer on this important work!

I’ve served as an interviewer for Harvard University for several years. Achievement so often comes down to the circumstances we’re born into. Affirmative action was imperfect, but it acknowledged this reality and allowed us to discover talents otherwise overlooked. Harvard Medical School Harvard Business School

We're excited to welcome our exceptional new resident classes! Glad to have you here at Duke #RadOnc 💙 Duke Cancer Duke University School of Medicine

Neurotoxicity and management of primary and secondary CNS lymphoma after adoptive immunotherapy with CD19-directed CAR T-cells academic.oup.com/neuro-oncology…

Couldn’t agree more!

Brief review re: targeting mutant IDH in gliomas by Drs. Reardon & Cahill As noted by authors to go 15 years from discovery to targeted therapy is impressive. doi.org/10.1038/s41571…

Eugene Vaios, MD MBA Kristen Gendron Aarti Kochhar & rqian: As alumni interested in leadership, you may like this post from the #HBR archives in case you missed it, tinyurl.com/4cy38avs

Fantastic work Sebastian F. Winter, MD PhD!